Zurich Cantonal Bank
NVO

Zurich Cantonal Bank’s Novo Nordisk NVO Stock Holding History

Zurich Cantonal Bank’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$440K Buy
9,169
+983
+12% +$42.2K ﹤0.01% 2012
2026
Q1 		$301K Buy
8,186
+3,419
+72% +$162K ﹤0.01% 2096
2025
Q4 		$243K Sell
4,767
-16,200
-77% -$828K ﹤0.01% 2156
2025
Q3 		$1.16M Buy
20,967
+14,068
+204% +$823K ﹤0.01% 1200
2025
Q2 		$476K Buy
6,899
+6,307
+1,065% +$429K ﹤0.01% 1699
2025
Q1 		$41.1K Buy
+592
New +$48.9K ﹤0.01% 2532

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Zurich Cantonal Bank's NVO Position: Q2 2026 in Review

Zurich Cantonal Bank increased its Novo Nordisk (NVO) stake by 12% in Q2 2026, buying an estimated $42.2K and bringing the position to 9,169 shares worth $440K. The position accounts for ﹤0.01% of the portfolio, ranked #2012.

Zurich Cantonal Bank first reported a position in NVO in Q1 2025 and has held it in 6 quarters since. The position peaked at $1.16M in Q3 2025. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Zurich Cantonal Bank held 9,169 shares of Novo Nordisk worth $440K as of Q2 2026.
  • Zurich Cantonal Bank bought 983 Novo Nordisk shares in Q2 2026, an estimated $42.2K.
  • Novo Nordisk made up ﹤0.01% of Zurich Cantonal Bank's portfolio in Q2 2026, its #2012 holding.
  • Zurich Cantonal Bank first reported a position in Novo Nordisk in Q1 2025 and has held it in 6 quarters since.
  • Zurich Cantonal Bank's Novo Nordisk position peaked at $1.16M in Q3 2025.
  • 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Zurich Cantonal Bank's 13F filing for Q2 2026, filed 12 Aug 2026.